Evidence map›Paper›PMID 38802340›Full record

ArticleNature communications2024

Proximal protein landscapes of the type I interferon signaling cascade reveal negative regulation by PJA2.

Samira Schiefer, Benjamin G Hale

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Ubiquitination in cancer: mechanisms and therapeutic opportunities.Cancer communications (London, England) · 2025
    Review
  7. Article
  8. An atlas of protein phosphorylation dynamics during interferon signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Samira SchieferInstitute of Medical Virology, University of Zurich, 8057, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9422-5646
Benjamin G HaleInstitute of Medical Virology, University of Zurich, 8057, Zurich, Switzerland. hale.ben@virology.uzh.ch.ORCID http://orcid.org/0000-0002-3891-9480

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_214957Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 31003A_182464
6 · The paper itself

Abstract

Deciphering the intricate dynamic events governing type I interferon (IFN) signaling is critical to unravel key regulatory mechanisms in host antiviral defense. Here, we leverage TurboID-based proximity labeling coupled with affinity purification-mass spectrometry to comprehensively map the proximal human proteomes of all seven canonical type I IFN signaling cascade members under basal and IFN-stimulated conditions. This uncovers a network of 103 high-confidence proteins in close proximity to the core members IFNAR1, IFNAR2, JAK1, TYK2, STAT1, STAT2, and IRF9, and validates several known constitutive protein assemblies, while also revealing novel stimulus-dependent and -independent associations between key signaling molecules. Functional screening further identifies PJA2 as a negative regulator of IFN signaling via its E3 ubiquitin ligase activity. Mechanistically, PJA2 interacts with TYK2 and JAK1, promotes their non-degradative ubiquitination, and limits the activating phosphorylation of TYK2 thereby restraining downstream STAT signaling. Our high-resolution proximal protein landscapes provide global insights into the type I IFN signaling network, and serve as a valuable resource for future exploration of its functional complexities.

Indexed as

Interferon Type IJanus Kinase 1Receptor, Interferon alpha-betaSignal TransductionSTAT2 Transcription FactorTYK2 KinaseUbiquitinationHEK293 CellsHumansInterferon-Stimulated Gene Factor 3, gamma SubunitPhosphorylationProteomeSTAT1 Transcription FactorUbiquitin-Protein LigasesIFNAR1 protein, humanIFNAR2 protein, humanInterferon-Stimulated Gene Factor 3, gamma SubunitInterferon Type IIRF9 protein, humanJAK1 protein, humanJanus Kinase 1PJA2 protein, humanProteomeReceptor, Interferon alpha-betaSTAT1 protein, humanSTAT1 Transcription FactorSTAT2 protein, humanSTAT2 Transcription FactorTYK2 KinaseTYK2 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID38802340
PMCPMC11130243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.